PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Posting of Scheme Document an

14 May 2008 10:30

RNS Number : 4023U
Virotec International PLC
14 May 2008
 

Virotec International plc

14 May 2008

Virotec International plc ("Virotec" or the "Company")

Posting of Scheme Document and Annual Report and Accounts

On 7 May 2008 the Virotec Independent Directors and Hydrodec Independent Directors confirmed that they had conditionally agreed the terms of a recommended acquisition of Virotec whereby Hydrodec Group plc ("Hydrodec"will acquire, for shares and cash, the entire issued and to be issued ordinary share capital of Virotec, to be effected by means of a scheme of arrangement under sections 895 to 901 of the Companies Act 2006 (the "Scheme").

Virotec announces that a circular (the "Scheme Document"), which sets out the full terms and conditions of the Scheme and an explanatory statement, together with the action to be taken by Virotec shareholders, has been posted to Virotec`s shareholders.

Subject to the satisfaction or waiver of the relevant conditions it is currently expected that the Scheme will become effective on 25 June 2008. 

Capitalised terms used, but not defined, in this announcement have the same meanings as given to them in the Scheme Document.

Additionally, Virotec announces that its annual report and accounts for the year ended 31 December 2007 has been posted to shareholders and will shortly be made available for viewing on the Company's website (www.virotec.com) or from:

The Secretary
PO Box 1092
Oxenford
Queensland 4210
Australia
Tel: + 61 7 5573 3353

Enquiries

Virotec International plc +61 755 733 353

Angus Craig

Arden Partners plc +44 (0) 20 7398 1600

Christopher Hardie

Matthew Armitt

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPUSAKRWNRVARR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.